- Home
- KTCC vs GDTC Comparison
KTCC vs GDTC Comparison
Compare KTCC & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTCC
- GDTC
- Stock Information
- Founded
- KTCC 1969
- GDTC 2018
- Country
- KTCC United States
- GDTC Singapore
- Employees
- KTCC N/A
- GDTC N/A
- Industry
- KTCC Electrical Products
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- KTCC Technology
- GDTC Health Care
- Exchange
- KTCC Nasdaq
- GDTC Nasdaq
- Market Cap
- KTCC 34.0M
- GDTC 28.0M
- IPO Year
- KTCC N/A
- GDTC 2023
- Fundamental
- Price
- KTCC $2.95
- GDTC $2.08
- Analyst Decision
- KTCC
- GDTC Buy
- Analyst Count
- KTCC 0
- GDTC 1
- Target Price
- KTCC N/A
- GDTC $5.00
- AVG Volume (30 Days)
- KTCC 26.3K
- GDTC 5.7K
- Earning Date
- KTCC 08-12-2025
- GDTC 01-01-0001
- Dividend Yield
- KTCC N/A
- GDTC N/A
- EPS Growth
- KTCC N/A
- GDTC N/A
- EPS
- KTCC N/A
- GDTC N/A
- Revenue
- KTCC $483,941,000.00
- GDTC $368,838.00
- Revenue This Year
- KTCC N/A
- GDTC $5.37
- Revenue Next Year
- KTCC N/A
- GDTC N/A
- P/E Ratio
- KTCC N/A
- GDTC N/A
- Revenue Growth
- KTCC N/A
- GDTC N/A
- 52 Week Low
- KTCC $2.21
- GDTC $1.20
- 52 Week High
- KTCC $6.14
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- KTCC 55.15
- GDTC 48.83
- Support Level
- KTCC $2.72
- GDTC $2.07
- Resistance Level
- KTCC $2.90
- GDTC $2.34
- Average True Range (ATR)
- KTCC 0.15
- GDTC 0.09
- MACD
- KTCC 0.00
- GDTC 0.00
- Stochastic Oscillator
- KTCC 71.43
- GDTC 50.97
About KTCC Key Tronic Corporation
Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.